Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial
阿特珠单抗联合贝伐珠单抗和化疗治疗转移性非鳞状非小细胞肺癌：随机双盲3期IMpower151试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03658-y
Zhou, Caicun; Dong, Xiaorong; Chen, Gongyan; Wang, Zhehai; Wu, Xianghua; Yao, Yu; Zhang, Yiping; Cheng, Ying; Pan, Hongming; Zhang, Xiaodong; Cui, Jiuwei; Wang, Lifeng; Chen, Xi; Li, Xiaoling; Wang, Ziping; Wang, Qiming; He, Jianxing; Wang, Mengzhao; Yan, Iris; Qian, Li; Xu, Miao; Huang, Xiayu; Sun, Chun; Cai, Jun; Wu, Qiong; Ballinger, Marcus; Kaul, Monika; Srivastava, Minu K
